Skip to main content
. 2022 Apr 13;29(1):1243–1256. doi: 10.1080/10717544.2022.2063454

Figure 3.

Figure 3.

Analysis of Fv-LDP-D3 and Fv-LDP-D3-AE bioactivity. (A) Fv-LDP-D3-induced inhibition of KYSE150, KYSE520, and Eca109 cell proliferation, as determined by CCK8 assay. (B) EGFR and IMPDH2 expression in different esophageal cancer cell lines were determined by western blot analysis. (C) Western blot analysis of EGFR and IMPDH2 expression in KYSE150 and KYSE520 cells treated with Fv-LDP-D3 for 24 h. (D) The cytotoxicity effects of Fv-LDP-D3-AE in different esophageal cancer cell lines were evaluated by CCK8 assays. (E) KYSE150 and Eca109 cells were treated with different concentrations of Fv-LDP-D3-AE for 24 h. Western blot analysis of EGFR and phosphor-EGFR expression. (F,G) The effect of Fv-LDP-D3-AE on the proliferation of KYSE150 and Eca109 cells was determined by EdU staining assays (Photo multiple, ×200). Results are reported as means ± standard deviation (SD) (n = 3). NS: no significance, *p < 0.05, **p < 0.01, ***p < 0.001 versus control group.